Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Editorial

    Editorial

    wadmin1By wadmin1September 1, 2019Updated:August 10, 2021No Comments1 Min Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Ian Edwin Cock1,2,*
    1Environmental Futures Research Institute, Nathan Campus, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.
    2School of Natural Sciences, Nathan Campus, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.

    Pharmacognosy Communications,2019,9,4,123.
    DOI:10.5530/pc.2019.4.25
    Published:September 2019
    Type:Editorial

    ABSTRACT

    Dear Readers and Authors,

    I am pleased to bring you Volume 9, Issue 4 of Pharmacognosy Communications. In this issue we present new research reports examining the pharmacognosy of several important medicinal plants including two studies examining the antibacterial activity of the endemic Australian plant Tasmannia lanceolata (Poir.) A.C.Sm. against Yersinia enterolitica and Bacillus anthracis. A further study reports the hematopoietic effects of Amaranthus cruentus L. extract on cyclophosphamide induced toxicity in rats. We also include a study reporting the isolation of the ellagitannin corilagen from Phyllanthus maderaspatensis L. for the first time. The final study included in this issue reports that Cordyline rubra Otto and A. Dietr. leaf and fruit lack antibacterial activity against a panel of human pathogens. Whilst this study reports negative results, it is important that these be published to decrease redundancy in testing between different research groups. Read more. . . 

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up